13th Annual Meeting of the International Society Of Gastrointestinal Oncology (ISGIO)

13th Annual Meeting of the International Society Of Gastrointestinal Oncology (ISGIO) is organized by International Society Of Gastrointestinal Oncology (ISGIO) and would be held during Oct 27 - 28, 2016 at Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia, United States of America.

The target audience for this medical event basically for professionals actively engaged clinically or scientifically in all facets of GI cancer research and care, including oncologists, surgeons, radiologists, general scientists, fellows, young investigators, nurses and pharmacists.

This CME conference has been approved with 12.0 AMA PRA Category 1 Credit(s).

Educational Objectives :
After attending this activity, the participant will demonstrate the ability to:
• Identify recent advances and innovations in the treatment of GI malignancies within the past 12 months
• Describe emerging evidence from current clinical trials that may impact treatment decision making in GI oncology
• Formulate a multi-modal approach to the treatment of hepatocellular carcinoma
• Analyze how recent clinical trial data demonstrate a significant survival benefit with a combination chemotherapy regimen in patients with metastatic pancreatic cancer
• Define which patients benefited the most based on the results of 2 large colon cancer trials demonstrated that the addition of cetuximab to chemotherapy improves outcomes for all patients with normal KRAS, regardless of BRAF status
• Discuss the multicenter trial results that demonstrate that sunitinib, a multi-targeted TKI, may delay disease progression in patients with pancreatic neuroendocrine tumors, and contribute to increased survival
• Name the prognostic value of 8 molecular markers on relapse-free survival and stages II and III colon cancer.